{"In": [0], "the": [1, 36], "coronavirus": [2], "efficacy": [3], "(COVE)": [4], "phase": [5], "3": [6], "clinical": [7], "trial,": [8], "vaccine": [9, 67, 82], "recipients": [10, 70], "were": [11, 33, 57], "assessed": [12], "for": [13, 22, 116], "neutralizing": [14], "and": [15, 25, 41, 63, 78, 96, 111, 122], "binding": [16], "antibodies": [17], "as": [18, 26], "correlates": [19, 27, 108], "of": [20, 28, 38, 84, 109], "risk": [21, 62], "COVID-19": [23, 61, 120, 124], "disease": [24], "protection.": [29], "These": [30, 102], "immune": [31, 106], "markers": [32, 56], "measured": [34], "at": [35], "time": [37], "second": [39], "vaccination": [40], "4": [42], "weeks": [43], "later,": [44], "with": [45, 60, 66, 71], "values": [46], "reported": [47], "in": [48], "standardized": [49], "World": [50], "Health": [51], "Organization": [52], "international": [53], "units.": [54], "All": [55], "inversely": [58], "associated": [59, 65], "directly": [64], "efficacy.": [68], "Vaccine": [69], "postvaccination": [72], "50%": [73], "neutralization": [74], "titers": [75], "10,": [76], "100,": [77], "1000": [79], "had": [80], "estimated": [81], "efficacies": [83], "78%": [85], "(95%": [86], "confidence": [87], "interval,": [88], "54": [89], "to": [90, 94, 99], "89%),": [91], "91%": [92], "(87": [93], "94%),": [95], "96%": [97], "(94": [98], "98%),": [100], "respectively.": [101], "results": [103], "help": [104], "define": [105], "marker": [107], "protection": [110], "may": [112], "guide": [113], "approval": [114], "decisions": [115], "messenger": [117], "RNA": [118], "(mRNA)": [119], "vaccines": [121], "other": [123], "vaccines.": [125]}